Conversely, miR-330-3p acts an oncogenic factor in glioblastoma by enhancing proliferation, invasion and inhibiting apoptosis through activation of ERK and PI3K/AKT pathways [38, 39]. The gene discussed is AKT1; the disease is glioblastoma.